TORNTPHARM.NS
TORNTPHARM.NS
INE685A01028
TORRENT PHARMACEUTICALS L
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.77T EUR
1.76T EUR
1.43T EUR
1.3T EUR
Enterprise Value
1.79T EUR
1.76T EUR
1.57T EUR
1.3T EUR
Valuation Multiples
Trailing P/E
74.39x
80.63x
66.03x
73.42x
Forward P/E
49.92x
--
--
--
Price to Sales
11.27x
11.37x
10.39x
13.53x
Price to Book
18.79x
--
17.03x
--
EV/Revenue
11.42x
11.37x
11.4x
13.53x
EV/EBITDA
37.29x
34.33x
35.1x
41.67x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
--
--
--
ende